0
Following
1
Follower
0
Boost

Rising Incidence of Cancer to Boost the Global Radiotherapy Market

Radiotherapy is a type of medical treatment that uses a specific amount of radiation to kill cancer cells and shrink tumors in patients. According to an NCBI study, radiation therapy is used to treat roughly 50% of cancer survivors, making up about 40% of curative cancer treatments. With a CAGR of 5.71% over the projection period of 2021–2030, the global radiotherapy market size was estimated to be $6.50 billion in 2021 and is expected to increase to $10.71 billion by 2030. The Rising Cases of Cancer Are Predicted to Drive the Growth of The Radiotherapy Market. The rising incidence of cancer, such as prostate, lung, and breast cancer, is boosting the demand for radiotherapy. Globally, the rising prevalence of oncology diseases such as prostate, lung, and breast cancer is increasing the demand for time management to reduce mortality associated with such conditions. Cancer is one of the primary causes of death worldwide, killing an estimated 9.6 million people in 2018. Cancer kills approximately 70% of people in low- and middle-income countries. Late-stage diagnosis and inaccessible treatment are the primary causes of rising cancer mortality rates worldwide. According to the National Cancer Institute 2020 report, an estimated 1,806,590 new cancer cases will be detected in the United States in 2020, with 606,520 people dying from the disease. Prostate, lung, and colorectal cancers are expected to account for 43% of all cancers diagnosed in men in 2020. Breast cancer, lung, and colorectal cancers are the most common cancers in women, accounting for an estimated 50% of new cancer diagnoses in women in 2020. By 2040, new cancer cases annually are expected to reach 29.5 million, with 16.4 million cancer-related deaths. Higher Efficiency of Radiotherapy Equipment with Enhanced Clinical Outcomes to Drive the Market Growth High-energy radiation in radiotherapy permanently damages cancer cells' DNA, causing them to die. As per the Mayo Foundation for Medical Education and Research, by July 2020, nearly half of all cancer patients will get radiotherapy as part of their treatment. Furthermore, according to NHS inform data, by November 2021, 4 out of every ten cancer cures will include radiotherapy as part of the treatment plan.
healthcare
Health
+ 4 interests

The Contrast Media Injectors Market forecast suggests that it is likely to reach a landmark of around USD 2.87 billion by 2030

The report "Contrast Media Injectors" Market By Product {Consumables (Tubes, Syringes, and Other Consumables), Injector Systems (MRI Injectors, CT Injectors, & Cardiovascular Injectors), and Accessories}, By Type (Syringe less Injectors, Dual-Head Injectors, and Single Head Injectors), By Applications (Interventional Radiology, Radiology, and Interventional Cardiology), By End-User (Hospitals, ASCs (Ambulatory Surgical Centres), and Others), and By Region (North America, Europe, Asia-Pacific, and LAMEA) - Global Forecast to 2030. "The Global Contrast Media Injectors Market's revenue was USD 1.37 billion in 2020. It is predicted to reach around USD 2.87 billion by 2030, representing a CAGR of 7.65 % throughout the forecasted time frame of 2020-2030. Pivotal factors that are expediting the market growth · The continuous rise in the number of cancer cases and cardiovascular diseases worldwide are the major factors that are augmenting the overall market growth. The World Health Organization stated that cancer is one of the leading causes of fatalities resulting in around 10 Mn deaths across the globe in 2020. The most common reasons for fatalities due to cancer in 2020 were lung cancer (around 1.80 Mn deaths), colon and rectum cancer (around 916,000 deaths), liver cancer (830,000 deaths), stomach cancer (approximately 769 000 deaths) and breast cancer (around 685,000 deaths). On the other hand, the CDC (Centre for Disease Control and Prevention) stated that in the USA, at least one individual dies every 36 seconds due to CVDs (Cardiovascular diseases), and approximately 659,000 people die each year which results in 1 out of every 4 deaths across the country. · Apart from the growing prevalence of CVDs and cancer, the rise in usage of consumables for the purpose of conducting various diagnostic procedures, the increase in the number of approvals for contrast agents and the enhancement of funds by the government bodies across the world are driving the market growth efficiently. Based on Product, the 'Injector Systems' segment held the largest proportion of the market share in 2020
healthcare
Health
+ 3 interests

Various Suitable Techniques Adopted by the Surgeons for Endovascular Aortic Aneurysm Repair (Evar)

EVAR, or Endovascular aneurysm repair, is one of the most crucial advances in the treatment of abdominal aortic aneurysm (AAA). EVAR is performed by inserting graft components that are entirely compressed & enfolded within a delivery sheath through the lumen of an access vessel, which is usually called the common femoral artery. Compared to the open AAA repair, the EVAR has shown a significant reduction in the number of perioperative mortalities, primarily because EVAR doesn't need an operative exposure of the aorta. Since the approval of the endograft devices in the U.S, there has been almost a 600 % increase in the number of EVAR procedures performed, out of which EVAR accounted for nearly 50 % of the total AAA repairs. Various techniques that have been employed by surgeons across the globe for EVAR are as follows: Selection of a proper endograft During the designing process of an aortic endograft, the key components that should be considered are proper stent selection, the delivery system, and the graft material. The ideal endograft design must be highly versatile in treating a wide range of patients worldwide. To fulfill this requirement, the endograft must display a higher degree of dimensional adaptability. A modular bifurcated endograft design allows intraoperative customization in tailoring the device to each patient's pathology and anatomy. Angiography
healthcare
Health
+ 2 interests